Barclays raised the firm’s price target on TransDigm to $1,500 from $1,250 and keeps an Overweight rating on the shares. The analyst updated the company’s model post the fiscal Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDG:
- TransDigm price target raised to $1,550 from $1,275 at Morgan Stanley
- TransDigm price target raised to $1,200 from $1,100 at Susquehanna
- TransDigm price target raised to $1,400 from $1,300 at TD Cowen
- TransDigm price target raised to $1,400 from $1,300 at RBC Capital
- TransDigm price target raised to $1,357 from $1,290 at Baird